Keyphrases
Peru
100%
Human Toxocariasis
100%
Toxocara
61%
Liver Transplantation
57%
Serodiagnosis
48%
Serology
45%
Lima
35%
Hepatocellular Carcinoma
32%
Cross-reactivity
32%
Excretory-secretory Antigen
31%
Risk Factors
30%
Hepatitis A
30%
Toxocara Infection
29%
Toxocariasis
29%
Hepatitis B
28%
Latin American
25%
Toxocara Canis
25%
IgG Test
25%
Contamination Sources
24%
Schoolchildren
24%
Mycoplasma Detection
24%
Mouse Cell Line
24%
Cajamarca
24%
Blastocystis
24%
Vero Cells
24%
Eosinophilia
20%
Seropositivity
20%
Stool Samples
17%
Helminth Infection
17%
Seroprevalence
16%
Vaccination
16%
IgG Antibody
15%
IgG ELISA
15%
Pathogenic Role
15%
Dot-ELISA
15%
Clinical Evidence
15%
Serological Evidence
15%
ELISA Test
15%
Latin America (LATAM)
15%
Hepatocellular Carcinoma Recurrence
14%
Blood Samples
14%
NS-1
14%
Cysticercosis
14%
Enzyme-linked Immunoelectrotransfer Blot
14%
National Hospital
13%
Human Being
13%
Healthy Individuals
12%
Ocular Manifestations
12%
Hospitalized children
12%
Severe Lung Disease
12%
Human Isolates
12%
Culture Isolation
12%
Lambayeque
12%
Health Surveys
12%
Respiratory Secretions
12%
Lophomonas
12%
O-glycosylation
12%
Toxocarosis
12%
Paragonimus
12%
Liver
12%
Pregnant Adolescents
12%
COVID-19
12%
Non-alcoholic Fatty Liver Disease (NAFLD)
12%
Active Immunization
12%
Allograft
12%
COVID-19 Impact
12%
Practice Guidance
12%
Infection Factors
12%
Portal Vein Thrombosis
12%
Primary Nonfunction
12%
Amazonian Cities
12%
Public Health
12%
Hepatic Damage
12%
Number of Sexual Partners
12%
Andean Community
12%
Liver Disease
12%
Methylated Glycans
12%
Antigen Targeting
12%
Chronic Hepatitis B Virus Infection
12%
Comparison with a Standard
12%
Dot Immunobinding Assay
12%
Immunodiagnostics
12%
Immunodiagnosis
12%
Porcine Cysticercosis
12%
Viral Hepatitis A
12%
Natural History
12%
Immunoglobulin M Antibody
12%
Rural Population
12%
Molecular Identification
12%
IgM Antibody
12%
Seroepidemiological Survey
12%
Hepatitis B Infection
12%
Alpha-fetoprotein
12%
Multicenter Cohort
12%
Immunogenicity
12%
Ophidia
12%
Bothrops Atrox
12%
Venom
12%
Viperidae Venoms
12%
Immunoenzymatic Method
12%
Immunology and Microbiology
Toxocara
85%
ELISA
49%
Immunology
48%
Serology
44%
Cross-Reactivity
27%
Helminthiasis
25%
Mycoplasma
24%
Cell Line
24%
Liver Transplantation
24%
Enzyme-Linked Immunosorbent Assay
19%
Toxocara canis
19%
Seroprevalence
16%
Cysticercosis
16%
Immunoglobulin G
16%
Normal Human
15%
Glycan
14%
Seropositivity
14%
Protista
12%
Light Microscopy
12%
Cytopathic Effect
12%
Rural Population
12%
Deglycosylation
12%
Heredity
12%
Paragonimiasis
12%
Secretion (Process)
12%
Immunodiagnostics
12%
Paragonimus
12%
Pig
12%
Hepatitis B
12%
Immunoglobulin M Antibody
12%
Alpha Fetoprotein
12%
Biological Factor
12%
Western Blot
10%
Human
10%
Hepatitis B Virus
9%
Pet Animal
9%
Intestine Parasite
9%
Helminth
6%
Blastocystis Hominis
6%
Giardia intestinalis
6%
Lower Respiratory Tract
6%
Hymenolepis Nana
6%
Chlorocebus Aethiops
6%
Staining
6%
Cell Membrane
6%
Ascaris lumbricoides
6%
Myeloma Cell Line
6%
Cell Culture
6%
Entamoeba Histolytica
6%
Dilution
6%
Sorafenib
6%
Canis
5%
Immunoglobulin M
5%
Medicine and Dentistry
Infection
41%
Hepatitis B
36%
Hepatocellular Carcinoma
34%
Liver Transplantation
32%
Liver Graft
25%
Prevalence
24%
Toxocariasis
24%
Hepatitis B Virus
21%
Transplantation
17%
Public Health
15%
Nonalcoholic Fatty Liver
13%
Silo-Filler's Disease
12%
Phlebothrombosis
12%
Eosinophilia
12%
Health Survey
12%
Pregnant Adolescent
12%
Paragonimus
12%
Paragonimiasis
12%
COVID-19
12%
Portal Vein Thrombosis
12%
Allograft
12%
Secretion (Process)
12%
Cohort Effect
12%
Liver Disease
12%
Chronic Hepatitis B
12%
Seroprevalence
12%
Pathogen
12%
Kingdom Chromista
12%
Alpha-Fetoprotein
12%
Disease
9%
Liver Cirrhosis
9%
Intensive Care Unit
8%
Enzyme Linked Immunosorbent Assay
8%
Retransplantation
8%
Cross Sectional Study
7%
Recurrent Disease
6%
Lavage
6%
Lower Respiratory Tract
6%
Tracheal Aspiration Procedure
6%
Atelectasis
6%
Pediatric Disease
6%
Respiratory Tract Infection
6%
Hepatitis B Antigen
6%
Immunity
6%
Immune Response
5%
Milan Criteria
5%
Hazard Ratio
5%
Hepatitis B(e) Antigen
5%